Use of prophylactic antibiotics, blood transfusion during acute esophageal variceal bleeding

碩士 === 義守大學 === 醫務管理學系 === 102 === This study deals with a teaching hospital for patients with acute esophageal variceal bleeding acceptance of the number of standard treatment procedures, rebleeding rate after treatment, infection and survival of the situation, compared with the patients who did n...

Full description

Bibliographic Details
Main Authors: Hui-Chen Lin, 林惠珍
Other Authors: Gin-Ho Lo
Format: Others
Language:zh-TW
Published: 2014
Online Access:http://ndltd.ncl.edu.tw/handle/41260522890474810118
Description
Summary:碩士 === 義守大學 === 醫務管理學系 === 102 === This study deals with a teaching hospital for patients with acute esophageal variceal bleeding acceptance of the number of standard treatment procedures, rebleeding rate after treatment, infection and survival of the situation, compared with the patients who did not receive the standard treatment procedures. This study was conducted to investigate patients with acute esophageal variceal (EV) bleeding, who were admitted to the hospital between January 2005 to December 2006, 90 patients; and January to December 2012, 113 patients; were retrospectively analyzed. Regarding the use of vasoconstrictors, 90% 2005-2006 cohort and 95% in the 2012 cohort had this combination (p=0.22). Use of prophylactic antibiotics was 6.8% in the 2005-2006 cohort and 83% in the 2012 cohort (p<0.05). The frequency of blood transfusion in hemoglobin>7g/dl was 67% and 85%, respectively. Rebleeding rates were similar between the 2 cohorts, irrespective of vasoconstrictor, prophylactic antibiotic or blood transfusion. Conclusion::(1)The frequency of using vasoconstrictor was no significant different in the two cohort, in more than 90%.(2)Use of prophylactic antibiotics in 2012 cohort has increased significantly.(3)The frequency of blood transfusions in hemoglobin <7g/dl was still very high in the two cohort.(4)By the analysis of the above factors seen in acute variceal bleeding aside from endoscopic therapy, the concept of using prophylactic antibiotics and vasoconstrictor agents have been deeply rooted in the hearts and implemented by clinicians, but transfusions policy has a room to be improved.